Xponance’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Buy |
|
|||||
|
2025
Q1 | $455K | Buy |
|
|||||
|
2024
Q4 | $513K | Buy |
|
|||||
|
2024
Q3 | $626K | Buy |
|
|||||
|
2024
Q2 | $456K | Buy |
|
|||||
|
2024
Q1 | $458K | Sell |
|
|||||
|
2023
Q4 | $486K | Buy |
|
|||||
|
2023
Q3 | $339K | Buy |
|
|||||
|
2023
Q2 | $436K | Buy |
|
|||||
|
2023
Q1 | $306K | Sell |
|
|||||
|
2022
Q4 | $357K | Buy |
|
|||||
|
2022
Q3 | $263K | Sell |
|
|||||
|
2022
Q2 | $385K | Buy |
|
|||||
|
2022
Q1 | $414K | Sell |
|
|||||
|
2021
Q4 | $481K | Buy |
|
|||||
|
2021
Q3 | $507K | Sell |
|
|||||
|
2021
Q2 | $552K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $254K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $205K | Buy |
|